In the LNCaP prostate cancer cell line DDAH2 was more strongly expressed when compared to benign prostate hypertrophy cells, and was also accompanied by increased eNOS, iNOS, and VEGF expression (184). The gene discussed is VEGFA; the disease is prostate carcinoma.